FAAH and rheumatoid arthritis: The plasma concentrations of other endocannabinoids, including anandamide and other NAEs, were higher in patients with RA and OA receiving treatment than in healthy participants and might be an indicator of decreased FAAH (fatty acid amide hydrolase) activity in RA and, to a lesser degree, in OA.